Clinical Trial

Activity of Bioactive Natural Compounds as Potential Agonists of GLP1R

Study acronym: BIOBESICOM
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if natural bioactive compound jubenine works to reduce appetite and to favour weight loss. It will also learn about the safety of natural bioactive compound jubenine. The main questions it aims to answer are: Does natural bioactive compound jubenine reduce the hunger perception or increase the satiety perception, and, consequently, reduce food intake? What medical problems do participants have when taking natural bioactive compound jubenine? Researchers will compare natural bioactive compound jubenine to a placebo (a look-alike substance that contains no drug) to see if natural bioactive compound jubenine works to reduce food intake for obesity treatment. Participants will: Take natural bioactive compound jubenine or a placebo three times every day for 3 months. Visit the clinic once every 1 week for checkups and tests. Keep a diary of their symptoms and potenital adverse effects.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06513715
Lead Sponsor Universidad Católica San Antonio de Murcia
Conditions Obesity, Overweight
Enrollment 100 participants
Start Date 2024-01-09
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-22